Evidence map›Paper›PMID 25916737›Full record

Observational studyClinical research in cardiology : official journal of the German Cardiac Society2015

Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients.

Christian Ott, Joanna M Harazny, Axel Schmid, Tilmann Ditting, Roland Veelken, Marek Bladowski, Georg Michelson, Michael Uder, Roland E Schmieder

Registry-linked trialAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical research in cardiology : official journal of the German Cardiac Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01687725 (Renal Denervation in Treatment Resistant Hypertension), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01687725 completednot on this map

Renal Denervation in Treatment Resistant Hypertension

TypeobservationalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2010 to 2018Enrolled41ConditionsHypertensionArmsRenal denervation using Symplicity Catheter system
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Second denervation in a patient with resistant hypertension.Clinical research in cardiology : official journal of the German Cardiac Society · 2016
    Article
  5. Renal artery sympathetic denervation: observations from the UK experience.Clinical research in cardiology : official journal of the German Cardiac Society · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christian OttDepartment of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.
Joanna M Harazny
Axel Schmid
Tilmann Ditting
Roland Veelken
Marek Bladowski
Georg Michelson
Michael Uder
Roland E Schmieder

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh pulsatile pressure and flow in the arteries causes microvascular damage, and hence increased cardio-, and cerebrovascular complications. With advanced stages of hypertensive disease, an exaggerated pulsatile retinal capillary flow (RCF) has been shown, but data about interventional effect are missing.

methodsFifty-one patients with true treatment-resistant hypertension (TRH) underwent renal denervation (RDN) using the Symplicity Flex(™) catheter and were followed for 12 months. RCF was assessed non-invasively using Scanning laser Doppler flowmetry (SLDF) before, 6 (6 M), and 12 (12 M) months after RDN. RCF was measured in systole and diastole and pulsed RCF (difference of RCF in systole minus diastole) was calculated. In addition, flicker light-induced vasodilation (representing vasodilatory capacity) was assessed.

resultsSystolic and diastolic office blood pressure (BP) as well as 24-h ABPM decreased significantly 6 M and 12 M after RDN, compared to baseline values (all p < 0.001). There was a significant reduction of pulsed RCF 6 M (231 ± 81 versus 208 ± 68 AU, p = 0.046) and 12 M (194 ± 72 AU, p = 0.001) after RDN, whereas the mean RCF was unchanged. Moreover, there was a significant increase of flicker light-induced vasodilation after RDN (p = 0.043).

conclusionIn hypertensive patients with TRH, we observed a decrease of pulsed RCF 6 M and 12 M after RDN and an increase of vasodilatory capacity, in parallel to decreases in BP and heart rate. The reduction of pulsed RCF after RDN implies a decrease of shear stress on the vascular wall by the pulsed blood flow. This and the increment of vasodilatory capacity suggest an improvement of retinal (and potentially cerebral) microcirculation.

Indexed as

Autonomic DenervationBlood PressureMicrocirculationAgedAntihypertensive AgentsBlood Flow VelocityBlood Pressure Monitoring, AmbulatoryCapillariesDrug ResistanceFemaleHeart RateHumansHypertensionKidneyLaser-Doppler FlowmetryMaleAntihypertensive Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.